QNT Gives Back the Analyst Bounce and Slides Under the Whole Sell-Side Range

No News, Just Gravity

There is no company-specific catalyst behind this one. The perp is back to $71.80, down 11.95% over 24 hours, and what's actually happening is the analyst-initiation bounce unwinding. Two sessions ago QNT was at $76.85, having just reclaimed the ground it lost to Morgan Stanley's lone equal-weight call. At $71.80 the contract has given all of that back and then some — it now trades below Morgan Stanley's $78 target, which was the *lowest* number on the street. In other words, the entire published sell-side target range now sits above spot. No downgrade, no guidance cut, no failed milestone landed today. On a freshly public, low-float quantum name, this is just the market repricing last week's overreaction in the other direction.

The Bull Case the Tape Just Faded

The bounce QNT is unwinding came from a wall of sell-side coverage that hit the moment the post-IPO quiet period expired on June 29. Needham, Bank of America and Craig-Hallum all initiated around $100, JPMorgan came in Overweight near $97, and Evercore ISI set $98 — a consensus clustered in the low $90s, well above where the stock trades now. Morgan Stanley was the sole skeptic, initiating at equal-weight with a $78 target. None of those calls changed today. What changed is that the tape stopped extrapolating the bullish cluster, started respecting the one cautious number, and then pushed straight through it.

Why the Floor Is Thin

Strip out the analyst noise and QNT is an early-stage company priced like a finished one. Quantinuum's prospectus showed 2025 revenue of $30.9 million against a net loss of $192.6 million, and the trend deteriorated into 2026: first-quarter revenue fell 73% to roughly $5.2 million while the net loss widened to about $136.5 million, with R&D running more than five times revenue. That leaves the stock at a price-to-book multiple near 70x versus a peer-group average around 12x. Add a thin post-IPO float — Honeywell still controls close to half the voting power — and you have a name that already dropped below its $60 IPO price once when the underwriting syndicate stopped defending it. Double-digit days in either direction are the cost of admission here.